GMP Manufacturing - Boehringer Ingelheim Therapeutics in Ochsenhausen, Germany
GMP Manufacturing, capabilities, production of viral gene therapeutics, oncolytic viruses, oncolytics vaccines, drug substances, clinical trials, CDMO, end-to-end-process development, regulatory support, international guidelines, international standards, suspension cell culture, stability studies, release testing, chromatography, Depth Filtration, Ultra Filtration, Dia-Filtration, Market Supply, large scale GMP manufacturing
435
page-template,page-template-full_width,page-template-full_width-php,page,page-id-435,page-child,parent-pageid-410,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-13.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.6.0,vc_responsive

Manufacturing

GMP Manufacturing

Boehringer Ingelheim Therapeutics has GMP compliant multipurpose manufacturing capabilities in class C clean-room suites, specialized in the production of viral gene therapeutics, oncolytic viruses and oncolytic vaccines. When manufacturing drug substances with analytical characterization for clinical trials, Boehringer Ingelheim Therapeutics operates as a full CDMO with end-to-end process development and regulatory support.

 

All GMP manufacturing processes are performed with single-use equipment according to international guidelines and standards. Currently, the GMP manufacturing processes include:
> Suspension Cell Culture
> Depth Filtration
> Ultra-/Dia-Filtration
> Chromatography
> Release Testing
> Stability Studies

 

At Boehringer Ingelheim Therapeutics state of the art facilities are combined with long established practice of manufacturing experience. By close cooperation with research institutions and regulatory authorities, Boehringer Ingelheim Therapeutics ensures to manufacture according to the latest standards.
Boehringer Ingelheim Therapeutics has GMP compliant multipurpose manufacturing capabilities in class C clean-room suites, specialized in the production of viral gene therapeutics, oncolytic viruses and oncolytic vaccines. When manufacturing drug substances with analytical characterization for clinical trials, Boehringer Ingelheim Therapeutics operates as a full CDMO with end-to-end process development and regulatory support.

 

All GMP manufacturing processes are performed with single-use equipment according to international guidelines and standards. Currently, the GMP manufacturing processes include:
> Suspension Cell Culture
> Depth Filtration
> Ultra-/Dia-Filtration
> Chromatography
> Release Testing
> Stability Studies

 

At Boehringer Ingelheim Therapeutics state of the art facilities are combined with long established practice of manufacturing experience. By close cooperation with research institutions and regulatory authorities, Boehringer Ingelheim Therapeutics ensures to manufacture according to the latest standards.